Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002
Sputum secretory leukocyte inhibitor and Clara cell protein 16 levels are not altered after 6 month and 1 year smoking cessation Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008
Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Clara cell specific protein (CC16) after LPS inhalation in healthy subjects Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside Year: 2003
The cellular composition and macrophage phenotypes in induced sputum in smokers and ex-smokers with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Clara cells drive eosinophil accumulation in allergic asthma Source: Eur Respir J 2012; 39: 429-438 Year: 2012
Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects Source: Eur Respir J, 56 (2) 2002378; 10.1183/13993003.02378-2020 Year: 2020
Bronchial airway expression of mucin-related, ENaC and chloride channel genes in COPD and non-COPD smokers compared to former and never smokers Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020
Levels of histone deacetylace (HDAC) activity in induced sputum of smokers, non smokers and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 129s Year: 2005
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 Source: Eur Respir J, 55 (5) 2000688; 10.1183/13993003.00688-2020 Year: 2020
Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects Source: Eur Respir J 2002; 20: 1152-1161 Year: 2002
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010
Clara cell secretory protein (CC16): possibility of detection in exhaled breath condensate Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007
Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
Clara cell protein (CC16) in serum and urine after exercise challenge Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Neutrophil predominance phenotype in bronchial asthma. Therapeutic implication and the role of Clara cell 16-kD protein Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007
Effect of whole cigarette smoke exposure and CCSP on MUC5AC mucin production in primary cultures of human bronchial epithelial cells at air-liquid interface of COPD, smokers and control patients Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015